The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
about
An integrative network algorithm identifies age-associated differential methylation interactome hotspots targeting stem-cell differentiation pathwaysAberrant gene promoter methylation associated with sporadic multiple colorectal cancerGene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways.Wnt signalling in adenomas of familial adenomatous polyposis patients.Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.Low expression of RBMS3 and SFRP1 are associated with poor prognosis in patients with gastric cancer.MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation.In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.Defining the cancer master switch.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.Analysis of molecular alterations in laterally spreading tumors of the colorectum.A pedagogical walkthrough of computational modeling and simulation of Wnt signaling pathway using static causal models in MATLAB.Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line.Reorganisation of Wnt-response pathways in colorectal tumorigenesisMethylation of SFRP2 gene as a promising noninvasive biomarker using feces in colorectal cancer diagnosis: a systematic meta-analysis.Comparison of Automated and Manual DNA Isolation Methods for DNA Methylation Analysis of Biopsy, Fresh Frozen, and Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Samples.VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.Wnt Signaling Regulates Airway Epithelial Stem Cells in Adult Murine Submucosal Glands.Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis.Integration of prior biological knowledge and epigenetic information enhances the prediction accuracy of the Bayesian Wnt pathway.Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas
P2860
Q28709213-3F5302DE-4940-47C9-BBEE-397CD3A73272Q33526369-1E1E220E-0B78-4FAE-A9FD-DE539A9DF25AQ34102567-9F0A2D39-847B-413F-9301-786127D6F8B9Q34253633-D35E2393-168F-4B22-BC5D-CC22FF7C7944Q34306416-22759992-D1BE-46EA-ACC4-95963EDCC0E2Q37447944-DDCE4EA5-3DF5-4CF4-888F-82EF37B11A56Q37492137-3C4B1043-2B62-4FE5-B0F5-7B0E3EE2CBBAQ37716574-E847B08B-F213-491C-A1EC-F3669FF1FD40Q37834359-CE29E2CF-814F-42BA-9C20-9514F0C75327Q38751688-4BE4E711-E465-4921-8947-90C098536C9CQ39322003-4EB45F67-3D5E-4E5C-9F44-B021B75AC2B7Q39468284-853A8822-44D5-4880-9A71-2BFA58035DDDQ39542456-A55FC475-903C-4F0E-A54C-0F2E149D21F9Q39991582-60977DF7-F354-4929-8EED-58A7926DEBABQ41163984-5948D93C-AD36-45B4-803C-7520C649ACEFQ42175301-A61F338B-21A9-4DA4-9411-CDEFBDC33F25Q44973244-04D2AE38-8B31-4943-9DC9-0C4A5CCEB6D2Q45855554-1A3FFBCD-CCEE-4C19-BB0E-F14FA9E3C5D4Q50868942-2DEFDCE1-1F36-440C-869A-4C84C7DBAB01Q51047488-899092C2-5CD3-4317-B06B-53073FE8F3ECQ58053622-F7131999-E18A-4B1D-BBA2-87A12AF2CEC4
P2860
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@ast
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@en
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@nl
type
label
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@ast
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@en
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@nl
prefLabel
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@ast
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@en
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@nl
P2093
P2860
P3181
P356
P1476
The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
@en
P2093
D G Morton
G M Caldwell
G M Matthews
P2860
P2888
P3181
P356
10.1038/SJ.BJC.6602967
P407
P577
2006-03-27T00:00:00Z
P5875
P6179
1001749177